| Autoantibodies against type I IFNs in patients with life-threatening COVID-19 P Bastard, LB Rosen, Q Zhang, E Michailidis, HH Hoffmann, Y Zhang, ... Science 370 (6515), eabd4585, 2020 | 2532 | 2020 |
| Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 Q Zhang, P Bastard, Z Liu, J Le Pen, M Moncada-Velez, J Chen, M Ogishi, ... Science 370 (6515), eabd4570, 2020 | 2190 | 2020 |
| Genomewide association study of severe Covid-19 with respiratory failure Severe Covid-19 GWAS Group New England Journal of Medicine 383 (16), 1522-1534, 2020 | 1935 | 2020 |
| Mapping the human genetic architecture of COVID-19 Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ... Nature 600 (7889), 472-477, 2021 | 747 | 2021 |
| Feasibility and physiological effects of prone positioning in non-intubated patients with acute respiratory failure due to COVID-19 (PRON-COVID): a prospective cohort study A Coppo, G Bellani, D Winterton, M Di Pierro, A Soria, P Faverio, M Cairo, ... The Lancet Respiratory Medicine 8 (8), 765-774, 2020 | 572 | 2020 |
| Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ... Science immunology 6 (62), eabl4340, 2021 | 467 | 2021 |
| High rates of 30-day mortality in patients with cirrhosis and COVID-19 M Iavarone, R D'Ambrosio, A Soria, M Triolo, N Pugliese, P Del Poggio, ... Journal of hepatology 73 (5), 1063-1071, 2020 | 387 | 2020 |
| Hospital-acquired infections in critically ill patients with COVID-19 G Grasselli, V Scaravilli, D Mangioni, L Scudeller, L Alagna, M Bartoletti, ... Chest 160 (2), 454-465, 2021 | 349 | 2021 |
| X-linked recessive TLR7 deficiency in~ 1% of men under 60 years old with life-threatening COVID-19 T Asano, B Boisson, F Onodi, D Matuozzo, M Moncada-Velez, ... Science immunology 6 (62), eabl4348, 2021 | 347 | 2021 |
| An immune-based biomarker signature is associated with mortality in COVID-19 patients MS Abers, OM Delmonte, EE Ricotta, J Fintzi, DL Fink, AAA de Jesus, ... JCI insight 6 (1), 2021 | 332 | 2021 |
| Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses H Pan, R Peto, AMH Restrepo, MP Preziosi, V Sathiyamoorthy, QA Karim, ... The Lancet 399 (10339), 1941-1953, 2022 | 252 | 2022 |
| Assessment, diagnosis, and treatment of HIV-associated neurocognitive disorder: a consensus report of the mind exchange program Mind Exchange Working Group, A Antinori, G Arendt, I Grant, S Letendre, ... Clinical Infectious Diseases 56 (7), 1004-1017, 2013 | 224 | 2013 |
| Cytomegalovirus coinfection is associated with an increased risk of severe non–AIDS-defining events in a large cohort of HIV-infected patients M Lichtner, P Cicconi, S Vita, A Cozzi-Lepri, M Galli, S Lo Caputo, ... The Journal of infectious diseases 211 (2), 178-186, 2015 | 219 | 2015 |
| Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian … A Di Castelnuovo, M Bonaccio, S Costanzo, A Gialluisi, A Antinori, ... Nutrition, Metabolism and Cardiovascular Diseases 30 (11), 1899-1913, 2020 | 198 | 2020 |
| Magnitude and dynamics of the T-cell response to SARS-CoV-2 infection at both individual and population levels TM Snyder, RM Gittelman, M Klinger, DH May, EJ Osborne, R Taniguchi, ... MedRxiv, 2020 | 190 | 2020 |
| Incidence of adverse reactions in HIV patients treated with protease inhibitors: a cohort study P Bonfanti, L Valsecchi, F Parazzini, S Carradori, L Pusterla, P Fortuna, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 23 (3), 236-245, 2000 | 174 | 2000 |
| Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial F Perrone, MC Piccirillo, PA Ascierto, C Salvarani, R Parrella, AM Marata, ... Journal of translational medicine 18 (1), 405, 2020 | 150 | 2020 |
| HIV and metabolic syndrome: a comparison with the general population P Bonfanti, C Giannattasio, E Ricci, R Facchetti, E Rosella, M Franzetti, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 45 (4), 426-431, 2007 | 149 | 2007 |
| Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 … A Cozzi-Lepri, M Noguera-Julian, F Di Giallonardo, R Schuurman, ... Journal of antimicrobial chemotherapy 70 (3), 930-940, 2015 | 144 | 2015 |
| Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase–Producing K. pneumoniae Infections: A Retrospective Observational Multicenter Study M Tumbarello, F Raffaelli, M Giannella, E Mantengoli, A Mularoni, ... Clinical Infectious Diseases 73 (9), 1664-1676, 2021 | 139 | 2021 |
Giuseppe Vittorio De SocioClinica di Malattie Infettive, Azienda Ospedaliero-Universitaria di Perugia. Ospedale "Santa Maria在 ospedale.perugia.it 的电子邮件经过验证
